| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.29B | 24.29B | 26.42B | 27.12B | 31.14B | 28.20B |
| Gross Profit | 3.95B | 3.95B | 3.94B | 5.20B | 3.53B | 3.79B |
| EBITDA | 3.69B | 3.69B | 6.28B | 6.22B | 4.14B | 47.40M |
| Net Income | 2.36B | 2.36B | 2.54B | 2.06B | 2.17B | 1.70B |
Balance Sheet | ||||||
| Total Assets | 172.90B | 172.90B | 155.08B | 161.97B | 148.77B | 152.57B |
| Cash, Cash Equivalents and Short-Term Investments | 29.92B | 29.92B | 25.45B | 33.07B | 27.09B | 23.94B |
| Total Debt | 35.58B | 35.58B | 35.20B | 25.49B | 35.24B | 26.04B |
| Total Liabilities | 133.01B | 133.01B | 111.73B | 122.19B | 105.41B | 104.65B |
| Stockholders Equity | 39.86B | 39.86B | 43.33B | 55.69B | 53.84B | 58.44B |
Cash Flow | ||||||
| Free Cash Flow | 1.37B | 0.00 | 1.96B | 5.68B | 5.56B | -41.90M |
| Operating Cash Flow | 1.59B | 0.00 | 2.45B | 6.20B | 6.26B | 370.00M |
| Investing Cash Flow | 738.10M | 0.00 | 2.52B | 4.44B | 2.82B | 5.94B |
| Financing Cash Flow | 1.39B | 0.00 | -9.27B | -3.68B | -4.65B | -8.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $3.88B | 40.40 | 16.22% | ― | -0.64% | 168.51% | |
75 Outperform | $8.01B | 30.13 | 18.56% | 0.25% | 21.45% | 67.31% | |
71 Outperform | $5.27B | 18.46 | 5.69% | 17.03% | -7.74% | 2.27% | |
70 Outperform | $5.27B | 35.73 | 16.87% | 0.45% | 6.87% | 64.56% | |
65 Neutral | $4.16B | -145.34 | -2.31% | 0.09% | 19.22% | 78.83% | |
64 Neutral | $7.45B | 2.35 | 91.03% | ― | -1.81% | 1228.51% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |